Bartlett & Co’s Boston Scientific BSX Stock Holding History

Bartlett & Co’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$70K	Hold	1,248	–	–	﹤0.01%	636
2023 Q3	$66K	Buy	1,248 +758	+155%	+$39.8K	﹤0.01%	605
2023 Q2	$27K	Hold	490	–	–	﹤0.01%	764
2023 Q1	$25K	Hold	490	–	–	﹤0.01%	672
2022 Q4	$23K	Hold	490	–	–	﹤0.01%	698
2022 Q3	$19K	Sell	490 -49	-9%	-$1.97K	﹤0.01%	711
2022 Q2	$20K	Buy	539 +217	+67%	+$8.83K	﹤0.01%	736
2022 Q1	$14K	Buy	+322	New	+$14K	﹤0.01%	779
2021 Q4	–	Sell	-322	Closed	-$14K	–	469
2021 Q3	$14K	Sell	322 -33	-9%	-$1.46K	﹤0.01%	670
2021 Q2	$15K	Hold	355	–	–	﹤0.01%	652
2021 Q1	$14K	Hold	355	–	–	﹤0.01%	700
2020 Q4	$13K	Buy	355 +33	+10%	+$1.19K	﹤0.01%	704
2020 Q3	$12K	Hold	322	–	–	﹤0.01%	663
2020 Q2	$11K	Hold	322	–	–	﹤0.01%	664
2020 Q1	$11K	Buy	+322	New	+$12.6K	﹤0.01%	646
2019 Q3	$13K	Buy	+322	New	+$13.6K	﹤0.01%	706
2019 Q2	–	Sell	-27	Closed	-$1K	–	736
2019 Q1	$1K	Buy	+27	New	+$1.03K	﹤0.01%	664
2013 Q4	–	Sell	-1,400	Closed	-$16K	–	692
2013 Q3	$16K	Hold	1,400	–	–	﹤0.01%	545
2013 Q2	$13K	Buy	+1,400	New	+$11.9K	﹤0.01%	569

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bartlett & Co's BSX Position: Q4 2023 in Review

Bartlett & Co held its Boston Scientific (BSX) position steady in Q4 2023 at 1,248 shares worth $70K. The position accounts for ﹤0.01% of the portfolio, ranked #636.

Bartlett & Co first reported a position in BSX in Q2 2013 and has held it in 19 quarters since. 1,148 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

Bartlett & Co held 1,248 shares of Boston Scientific worth $70K as of Q4 2023.
Bartlett & Co left its Boston Scientific share count unchanged in Q4 2023.
Boston Scientific made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #636 holding.
Bartlett & Co first reported a position in Boston Scientific in Q2 2013 and has held it in 19 quarters since.
1,148 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.